Jenny Walsh Consulting Ltd offers specialist pharmaceutical development consultancy support to pharmaceutical, biotechnology and healthcare industries. The Company specialises in paediatric product development (from early phase prototypes to products for marketing) and technical writing.
Services offered include:
Support and independent impartial advice on paediatric formulation development strategies and projects
Writing and review of CMC regulatory documents, including Paediatric Investigation Plans
Literature reviews and authoring of technical reports
Tailored training on formulation of paediatric medicines
Assistance with pharmaceutical vendor selection and management
Bespoke support for pharmaceutical formulation activities (adult and paediatric products)
Regulations in both Europe and the USA mandate the development of paediatric medicines for new products and incentives are in place for the development of off-patent (generic) paediatric products. The formulation of medicines for children is challenging due to the diverse patient population and the need to consider patient acceptability and the safety of both excipients and the API.
Jenny Walsh is a PhD pharmacist with over 20 years experience in pharmaceutical and consumer healthcare product development where she has held a variety of roles within Pharmaceutical Development and Medical Affairs. She has recognised expertise in pharmaceutical product formulation and extensive experience of reviewing and writing technical and regulatory documents.
The services we offer allow customers to focus on their core competencies, meet their regulatory obligations and maximise potential opportunities.